IV-to-oral switch therapy with trovafloxacin compared with IV ceftazidime/oral ciprofloxacin in the treatment of nosocomial pneumonia

被引：2

作者：

Bassaris, HP

Hopkins, DW

Daniel, R

机构：

[1] Univ Patras, Sch Med, Dept Med, Infect Dis Sect, GR-26110 Rion Patras, Greece

[2] Pfizer Inc, Pfizer Cent Res, Groton, CT 06340 USA

[3] Pfizer Cent Res, Sandwich, Kent, England

来源：

DRUGS | 1999年 / 58卷 / Suppl 2期

关键词：

D O I：

10.2165/00003495-199958002-00104

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：309 / 311

页数：3

共 8 条

[1] Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy [J].

Andrews, JM ;

Honeybourne, D ;

Brenwald, NP ;

Bannerjee, D ;

Iredale, M ;

Cunningham, B ;

Wise, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (06) :797-802

[2] The chemistry and biological profile of trovafloxacin [J].

Brighty, KE ;

Gootz, TD .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :1-14

[3] INVITRO ACTIVITY OF CP-99,219, A NEW FLUOROQUINOLONE, AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE BACTERIA [J].

ELIOPOULOS, GM ;

KLIMM, K ;

ELIOPOULOS, CT ;

FERRARO, MJ ;

MOELLERING, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :366-370

[4] Susceptibility of anaerobic bacteria to trovafloxacin: Comparison with other quinolones and non-quinolone antibiotics [J].

Spangler, SK ;

Jacobs, MR ;

Appelbaum, PC .

INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 :S101-S109

[5]

TAYLOR A, 1997, P 37 INT C ANT AG CH, P14

[6] Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers [J].

Vincent, J ;

Teng, R ;

Dogolo, LC ;

Willavize, SA ;

Friedman, HL .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :81-86

[7] Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans [J].

Vincent J. ;

Dogolo L. ;

Baris B.A. ;

Willavize S.A. ;

Teng R. .

European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 (6) :427-430

[8]

VINCENT J, 1996, P 36 INT C ANT AG CH, P2

← 1 →